Trial intelligence / Profile preview

Ciprofol vs propofol total intravenous anesthesia in thyroid cancer surgery

ChiCTR2500114971Phase 4Not yet recruiting

Sponsor
Weifang People's Hospital
Start
Dec 2025
Modality
Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of ciprofol in thyroid cancer (2 arms), sponsored by Weifang People's Hospital. Primary endpoint: QoR-15 questionnaire score on postoperative day 1 (POD 1). Planned start Dec 2025; status: not yet recruiting.

02

Drugs

ciprofol
03

Conditions

thyroid cancer

Beyond the preview

Go deeper on ChiCTR2500114971.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500114971.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call